Public opinion on access to mifepristone in the U.S. in 2023. by age
As of May 2023, 70 percent of adults aged 65 years and above were of the opinion that access to mifepristone should remain the same in the United States. The majority of respondents across all age groups believed access to mifepristone should remain on the market in the U.S. in 2023.